Economics of Treatments for Non-Small Cell Lung Cancer

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.2, 2009-01, pp. : 113-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Taxanes for advanced non-small cell lung cancer

By Ramalingam Sakkaraiappan Belani Chandra P

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1693-1709

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine in non-small cell lung cancer

By Cappuzzo Federico Crinò Lucio

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 745-753

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare Maione Paolo Rossi Antonio Bareschino Maria Anna Schettino Clorinda Sacco Paola Claudia Zeppa Rosario

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite